...
首页> 外文期刊>Frontiers in Medicine >Syndrome Evaluation System for Simultaneous Detection Pathogens Causing Acute Encephalitic Syndrome in India, Part-1: Development and Standardization of the Assay
【24h】

Syndrome Evaluation System for Simultaneous Detection Pathogens Causing Acute Encephalitic Syndrome in India, Part-1: Development and Standardization of the Assay

机译:印度急性脑综合征的同时检测病原体的综合征评估系统,第1部分:分析方法的开发和标准化

获取原文

摘要

A large number of organisms are known to cause acute encephalitic syndrome (AES). A number of diagnostic tests have to be performed in order to arrive at a probable pathogen causing AES thus making it a very time consuming, laborious and expensive. The problem is further compounded by the lack of availability of sufficient volume of Cerebrospinal fluid (CSF). Thus, there is an urgent need of a diagnostic tool for the simultaneous detection of all probable pathogens responsible for causing AES. Here we report the development of a novel diagnostic method, Syndrome Evaluation System (SES) for the simultaneous detection of 22 pathogens including RNA and DNA Viruses, bacteria, fungi, and parasite all endemic to India and Southeast Asia in a single sample using a novel multiplexing strategy. Syndrome Evaluation System (SES) involves isolation of nucleic acid, multiplex amplification of the DNA, and cDNA followed by identification of the amplified product by sequence specific hybridization on SES platform with the final read out being a visually recordable colored signal. The total time required to carry out this diagnostic procedure is 7 h. The SES was standardized using the commercially available vaccines, panels and cell culture grown quantified viruses/bacteria/fungi. The limit of detection (LOD) of SES ranged between 0.1 and 50 viral particles per ml of CSF and 100 to 200 bacterial cells or 5 parasites per ml of CSF, along with 100% specificity. Precision studies carried out as per the Clinical Laboratory Improvement Amendments (CLIA) guidelines, using two concentrations of each pathogen one the LOD and the other double the LOD, clearly demonstrated, that inter/intra assay variability was within the limits prescribed by the guidelines. SES is a rapid molecular diagnostic tool for simultaneous identification of 22 etiological agents of AES encountered both in sporadic and outbreak settings.
机译:已知有许多生物会引起急性脑病综合征(AES)。为了找到可能引起AES的病原体,必须执行许多诊断测试,因此使其非常耗时,费力且昂贵。由于缺乏足够数量的脑脊髓液(CSF),该问题进一步恶化。因此,迫切需要用于同时检测引起AES的所有可能病原体的诊断工具。在这里,我们报告了一种新型诊断方法的发展,即综合评估系统(SES),可使用一种新型样本同时检测22种病原体,包括印度和东南亚流行的22种病原体,包括RNA和DNA病毒,细菌,真菌和寄生虫。复用策略。综合症评估系统(SES)涉及核酸的分离,DNA和cDNA的多重扩增,然后通过在SES平台上进行序列特异性杂交来鉴定扩增的产物,最终的读数是可通过视觉记录的彩色信号。进行此诊断过程所需的总时间为7小时。使用市售疫苗,面板和细胞培养生长的定量病毒/细菌/真菌对SES进行标准化。 SES的检出限(LOD)为每毫升CSF 0.1至50个病毒颗粒和每毫升CSF 100至200个细菌细胞或5个寄生虫,以及100%的特异性。根据临床实验室改进修正案(CLIA)指南进行的精密度研究,使用每种病原体的两种浓度,一种是LOD,另一种是LOD的两倍,清楚地表明,内部/内部分析的变异性在指南规定的范围内。 SES是一种快速分子诊断工具,可用于同时识别在散发和爆发环境中遇到的22种AES病原体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号